Close
Close
Treatment Database
Recombinant fusion protein linking human coagulation factor IX with human albumin
Trade Name IDELVION
Orphan Indication Haemophilia B
EU Market Approval 13-05-2016
EU Designation Date 04-02-2010
Sponsor CSL Behring GmbH
More about Hemophilia B
Free Newsletter
Treatment News
Related Videos
by Abidemi Uruejoma
190 views
by Abidemi Uruejoma
11,204 views